Authors:
LODDING P
AUS G
BERGDAHL S
FROSING R
PIHL CG
HUGOSSON J
LILJA H
Citation: P. Lodding et al., SCREENING DETECTED PROSTATE-CANCER (PC) IN MALES AGED 50-66 YEARS WITH PROSTATE-SPECIFIC ANTIGEN (PSA) WITHIN THE INTERVAL 3-4 NG ML/, The Journal of urology, 159(5), 1998, pp. 900-900
Authors:
LODDING P
AUS G
BERGDAHL S
FROSING R
LILJA H
PIHL CG
HUGOSSON J
Citation: P. Lodding et al., CHARACTERISTICS OF SCREENING DETECTED PROSTATE-CANCER IN MEN 50 TO 66YEARS OLD WITH 3 TO 4 NG. ML. PROSTATE-SPECIFIC ANTIGEN/, The Journal of urology, 159(3), 1998, pp. 899-903
Authors:
CARLSSON G
ODIN E
LARSSON PA
FROSING R
SPEARS CP
GUSTAVSSON B
Citation: G. Carlsson et al., PHASE I-II STUDY OF WEEKLY 5-FLUOROURACIL AND 5,10-METHYLENE-TETRAHYDROFOLATE IN PATIENTS WITH ADVANCED GASTROINTESTINAL AND BREAST-CANCER, The Cancer journal, 10(5), 1997, pp. 266-273
Authors:
HUGOSSON J
BERGDAHL S
CARLSSON G
FROSING R
NORLEN L
GUSTAVSSON B
Citation: J. Hugosson et al., EFFECTS OF INTRAVESICAL INSTILLATION OF 5-FLUOROURACIL AND INTERFERONIN PATIENTS WITH RECURRENT SUPERFICIAL URINARY-BLADDER CARCINOMA - A CLINICAL AND PHARMACODYNAMIC STUDY, Scandinavian journal of urology and nephrology, 31(4), 1997, pp. 343-347
Authors:
CARLSSON G
LARSSON PA
FROSING R
HAFSTROM LO
SPEARS CP
PETERSON A
GUSTAVSSON B
Citation: G. Carlsson et al., 5-FLUOROURACIL SENSITIVE ADENOCARCINOMA - A NEW EXPERIMENTAL-MODEL INTHE RAT, Anticancer research, 15(2), 1995, pp. 433-439